시장보고서
상품코드
1290555

세계의 신속 진단 시장 : 제품별, 처방별, 용도별, 최종사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)

Rapid Diagnostics Market, By Product, By Prescription, By Application, By End User, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

발행일: | 리서치사: Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

신속 진단 검사는 통상 30분 이내에 결과가 나오는 사용하기 편리한 검사입니다.30분 이내에 시행 가능하고, 병원체 존재를 신속하고 정확하게 탐지 하는 신속한 필드 테스트입니다.신속한 결과에 의해서, 헬스케어 전문가/종사자는 정보에 근거한 판단을 신속히 내려, 지역 레벨로 환자 생명을 지킬 수 있습니다.

시장 역학 :

감염증/만성질환 유병률 상승, COVID-19(팬데믹) 발생, POC(Point of Care) 진단 사용률 상승, 유리한 정부 이니셔티브, 조기진단에 관한 사람들 의식의 고양은 예측 기간중에 세계의 신속 진단 시장 성장을 지지할 것으로 예상되는 주요인입니다.

예를 들면, 2022년 3월, Brain Chemistry Labs와 Arlington Scientific는 사용하기 쉬운 신속 검사 키트를 개발하기 위해서 제휴했습니다.이 신속 검사 키트는 루게릭병(ALS)이라고 하는 치명적인 마비성 질환을 일으키는 시아노바크테리아 개화에 존재하는 독소인 B-methylamino-L-Alanine(BMAA)의 존재를 탐지하는 것입니다.

본 조사의 주요 특징

  • 본 보고서에서는 세계의 신속 진단 시장을 상세하게 분석하고 2022년을 기준년으로 한 예측 기간(2023-2030년) 시장 규모 및 CAGR을 제공합니다.
  • 또한 다양한 부문 잠재적인 매출 기회를 해명해, 이 시장에 대한 매력적인 투자 제안 매트릭스를 해설했습니다.
  • 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 발매 또는 승인, 시장 동향, 지역 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요 인사이트를 제공합니다.
  • 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등, 이하 파라미터에 근거하여 세계의 신속 진단 시장 주요 기업을 개요를 제공합니다.
  • 이 조사 일부로서 커버되고 있는 주요 기업은 Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, Ascensia Diabetes Care Holdings, 등입니다.
  • 본 보고서에서 얻을 수 있는 지견은 마케팅 담당자나 기업 경영진이 향후 제품 발매, 시장 확대, 마케팅 전술에 관한 정보에 근거한 결정을 내릴 수 있게 할 것입니다.
  • 본 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 재무 애널리스트 등, 이 업계 다양한 이해관계자를 대상으로 하고 있습니다.
  • 이해관계자는 세계의 신속 진단 시장 분석에 사용되는 다양한 전략 매트릭스를 통해서 의사결정을 용이하게 할 수 있습니다.

목차 :

제1장 조사 목적과 전제조건

  • 조사 목적
  • 전제조건
  • 약어

제2장 시장 전망

  • 보고서 개요
    • 시장 정의와 범위
  • 주요 요약
  • Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

  • 시장 역학
    • 만성질환/감염증 유병률 상승
    • 엄격한 규제와 신속 진단의 과제
    • COVID-19 발생(팬데믹)
  • 영향 분석
  • 주요 하이라이트
  • 규제 시나리오
  • 제품 발매/승인
  • PEST 분석
  • PORTER 분석
  • 인수합병(M&A) 시나리오

제4장 세계의 신속 진단 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

  • COVID-19 역학에 대해
  • 공급측과 수요측 분석
  • 경제적 영향

제5장 세계의 신속 진단 시장, 제품별, 2017년-2030년

  • 소모품
  • 기기/분석 장비

제6장 세계의 신속 진단 시장, 처방전별, 2017-2030년

  • 전문 진단
  • 가정용/OTC 기반 검사

제7장 세계의 신속 진단 시장 : 용도별, 2017년-2030년

  • 혈당 검사
  • 순환기계 검사
  • 감염증 검사
  • 혈액 응고 검사
  • 혈액 학적 검사
  • 암 검진
  • 남용 약물 검사
  • 임신/불임/배란 검사

제8장 세계의 신속 진단 시장, 최종사용자별, 2017년-2030년

  • 병원 및 진료소
  • 실험실
  • 개인/홈케어 환경
  • 기타

제9장 세계의 신속 진단 시장, 지역별, 2017년-2030년

  • 북미
  • 유럽
  • 아시아태평양
  • 라틴아메리카
  • 중동 및 아프리카

제10장 경쟁 구도

  • Abbott
  • Danaher
  • Quidel
  • BD
  • LifeScan
  • Siemens Healthineers
  • F. Hoffmann-La Roche
  • Ascensia Diabetes Care Holdings

제11장 섹션

  • 조사 방법에 대해
  • 출판사에 대해
LSH 23.06.30

Rapid diagnostic tests are easy-to-use tests that provide quick results, usually 30 in minutes or less. These are quick field tests that can be performed in under 30 minutes and detect the presence of a pathogen quickly and accurately. Rapid results enable healthcare professionals/workers to make informed decisions quickly and protect the lives of their patients at the community level.

Market Dynamics:

Rise in prevalence of infectious/chronic diseases, outbreak of COVID-19 (pandemic), rise in usage of point-of-care diagnostics, favorable government initiatives, and rising awareness among people regarding early diagnosis are major factors expected to boost growth of the global rapid diagnostics market during the forecast period.

For instance, in March 2022, Brain Chemistry Labs and Arlington Scientific teamed up to develop an easy-to-use rapid test kit. The rapid test kit will detect the presence of B-methylamino-L-Alanine (BMAA), a toxin present in cyanobacterial blooms, which causes a fatal paralytic disease called Amyotrophic Lateral Sclerosis (ALS).

Key features of the study:

  • This report provides in-depth analysis of the global rapid diagnostics market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global rapid diagnostics market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Abbott, Danaher, Quidel, BD, LifeScan, Siemens Healthineers, F. Hoffmann-La Roche, and Ascensia Diabetes Care Holdings, among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global rapid diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global rapid diagnostics market.

Detailed Segmentation:

  • Global Rapid Diagnostics Market, By Product:
    • Consumables
    • Instruments/Analysers
  • Global Rapid Diagnostics Market, By Prescription:
    • Professional Diagnostics
    • At-Home/OTC-Based Testing
  • Global Rapid Diagnostics Market, By Application:
    • Blood Glucose Testing
    • Cardiometabolic Testing
    • Infectious Disease Testing
    • Blood Coagulation Testing
    • Hematology Testing
    • Cancer Testing
    • Drug of Abuse Testing
    • Pregnancy and Fertility/Ovulation Testing
  • Global Rapid Diagnostics Market, By End User:
    • Hospitals and Clinics
    • Laboratories
    • Individuals/Home Healthcare Settings
    • Others
  • By Geography:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  • Company Profiles:
    • Abbott
    • Danaher
    • Quidel
    • BD
    • LifeScan
    • Siemens Healthineers
    • F. Hoffmann-La Roche
    • Ascensia Diabetes Care Holdings

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Prescription
    • Market Snapshot By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Geography
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Rise in prevalence of chronic/infectious disease
    • Stringent regulations and rapid diagnostics challenges
    • The outbreak of COVID-19 (global pandemic)
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Rapid Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Rapid Diagnostics Market, By Product, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Instruments/Analysers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

6. Global Rapid Diagnostics Market, By Prescription, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Professional Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • At-Home/OTC-Based Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

7. Global Rapid Diagnostics Market, By Application, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Blood Glucose Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cardiometabolic Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Infectious Disease Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Blood Coagulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Hematology Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Cancer Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Drug of Abuse Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Pregnancy and Fertility/Ovulation Testing
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

8. Global Rapid Diagnostics Market, By End User, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Hospitals and Clinics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Individuals/Home Healthcare Settings
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030,(US$ Bn)

9. Global Rapid Diagnostics Market, By Geography, 2017-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)
  • Middle East & Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Prescription, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017-2030,(US$ Bn)

10. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Danaher
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quidel
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • BD
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • LifeScan
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Siemens Healthineers
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F. Hoffmann-La Roche
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ascensia Diabetes Care Holdings
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Analyst Views

11. Section

  • Research Methodology
  • About us
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제